Vlagea et al. [45] carried out a study for the presence of anti-β2GPI IgA (cut-off >20 U/mL 99th percentile, 100 healthy follow-ups) in 314 patients with APS and SLE. Here, CD79A is linked to systemic lupus erythematosus.